63rd European Renal Association Congress (ERA 2026)
Glasgow, Scotland, UK 03 June 2026 - 06 June 2026
Pooled KARDIA data show effective BP control with add-on zilebesiran
07 Jul 2026
bởiAudrey Abella
A pooled analysis of data from the phase II KARDIA 2 and 3 studies shows the blood pressure (BP)-lowering potential of zilebesiran, an investigational, long-acting RNA interference therapeutic, when added to a renin–angiotensin–aldosterone system inhibitor (RAASi) in patients with hypertension (HTN).
